US Treasury Proposes Extending Outbound Investment Controls to Biotechnology Under the COINS Act – Chinese Pharma Access to US Capital Faces Tighter Restrictions

Proposed US Treasury Department regulations released on 22 October 2026 would extend existing US outbound investment controls to biotechnology, potentially affecting venture financing, equity‑linked licensing agreements, and cross‑border NewCo structures…